---
layout: default
title: Clomipramine
description: "Clomipramine çš„è€è—¥æ–°ç”¨æ½›åŠ›åˆ†æã€‚æ¨¡å‹é æ¸¬ç­‰ç´š L5ï¼ŒåŒ…å« 10 å€‹é æ¸¬é©æ‡‰ç—‡ã€‚æŸ¥çœ‹ AI é æ¸¬èˆ‡è‡¨åºŠè­‰æ“šå®Œæ•´å ±å‘Šã€‚"
parent: åƒ…æ¨¡å‹é æ¸¬ (L5)
nav_order: 50
evidence_level: L1
indication_count: 10
---

# Clomipramine

<p style="font-size: 1.25rem; color: #666; margin-bottom: 1.5rem;">
è­‰æ“šç­‰ç´š: <strong>L5</strong> | é æ¸¬é©æ‡‰ç—‡: <strong>10</strong> å€‹
</p>

---

<div id="pharmacist">

## è—¥å¸«è©•ä¼°å ±å‘Š

</div>

# Clomipramine è—¥å¸«ç­†è¨˜

## ä¸€å¥è©±ç¸½çµ

<p class="key-answer" data-question="Clomipramine å¯ä»¥ç”¨æ–¼æ²»ç™‚ä»€éº¼æ–°é©æ‡‰ç—‡ï¼Ÿ">
Clomipramine æ˜¯ç¶“å…¸çš„ä¸‰ç’°æŠ—æ†‚é¬±åŠ‘ï¼ŒTxGNN é æ¸¬å…¶å°ç„¦æ…®ç—‡æœ‰ç™‚æ•ˆï¼Œé€™èˆ‡å…¶å·²çŸ¥çš„è—¥ç†ä½œç”¨åŠè±å¯Œçš„è‡¨åºŠè­‰æ“šé«˜åº¦å»åˆï¼Œå±¬æ–¼è­‰æ“šå……è¶³çš„ã€Œè€è—¥æ—¢æœ‰ç”¨é€”ã€ã€‚
</p>

---

## å¿«é€Ÿç¸½è¦½

| é …ç›® | å…§å®¹ |
|------|------|
| è—¥ç‰©åç¨± | Clomipramine (å¯æ´›ç±³æ™®æ˜) |
| DrugBank ID | DB01242 |
| å°ç£å•†å“å | å€æ¬£è†œè¡£éŒ  25 å…¬çµ² ç­‰å¤šç¨®è£½åŠ‘ |
| åŸæ ¸å‡†é©æ‡‰ç—‡ | æ†‚é¬±ç—‡ã€å¼·è¿«ç—‡ã€ææ‡¼ç—‡ã€é©šæ‡¼ç™¼ä½œ |
| é æ¸¬æ–°é©æ‡‰ç—‡ | ç„¦æ…®ç—‡ã€obsessive-compulsive disorderã€benign paroxysmal torticollis of infancyã€schizotypal personality disorderã€histrionic personality disorder (disease)ã€paranoid personality disorderã€schizoid personality disorderã€agoraphobiaã€major depressive disorderã€endogenous depression |
| æœ€é«˜é æ¸¬åˆ†æ•¸ | 0.999 (anxiety disorder) |
| è­‰æ“šç­‰ç´š | L1-L2 (å¤šå€‹ RCT/ç³»çµ±æ€§å›é¡§) |

---





## é æ¸¬é©æ‡‰ç—‡è©³ç´°åˆ†æ

<details class="indication-section" open>
<summary>
<span class="indication-name">1. anxiety disorder</span>
<span class="evidence-badge evidence-L1">L1</span>
<span class="prediction-score">99.93%</span> <span class="primary-badge">ä¸»è¦åˆ†æ</span>
</summary>
<div class="indication-content">

<h3>ç‚ºä»€éº¼é€™å€‹é æ¸¬åˆç†ï¼Ÿ</h3>

<p>Clomipramine çš„è—¥ç†æ©Ÿè½‰å®Œå…¨æ”¯æŒå…¶å°ç„¦æ…®ç—‡çš„ç™‚æ•ˆï¼š</p>

<ol>
<li><strong>è¡€æ¸…ç´ å†å¸æ”¶æŠ‘åˆ¶</strong>ï¼šClomipramine æ˜¯ä¸‰ç’°æŠ—æ†‚é¬±åŠ‘ä¸­è¡€æ¸…ç´ é¸æ“‡æ€§æœ€é«˜è€…ï¼Œå…¶æ´»æ€§ä»£è¬ç‰© desmethylclomipramine å‰‡æŠ‘åˆ¶æ­£è…ä¸Šè…ºç´ å†å¸æ”¶</li>
<li><strong>æŠ—ç„¦æ…®æ©Ÿè½‰æ˜ç¢º</strong>ï¼šè¡€æ¸…ç´ ç³»çµ±å¤±èª¿æ˜¯ç„¦æ…®ç—‡çš„æ ¸å¿ƒç—…ç†æ©Ÿè½‰ï¼Œå¢åŠ è¡€æ¸…ç´ å‚³å°å¯æ”¹å–„ç„¦æ…®ç—‡ç‹€</li>
<li><strong>è‡¨åºŠç¶“é©—è±å¯Œ</strong>ï¼šClomipramine å·²å»£æ³›ç”¨æ–¼å¼·è¿«ç—‡ (OCD)ã€ææ…Œç—‡ç­‰ç„¦æ…®ç›¸é—œç–¾æ‚£ï¼Œç™‚æ•ˆç¢ºç«‹</li>

</ol>
<p>å¯¦éš›ä¸Šï¼Œã€Œç„¦æ…®ç—‡ã€çš„é æ¸¬åæ˜ çš„æ˜¯ clomipramine å·²çŸ¥çš„æ²»ç™‚è­œç³»ï¼Œè€ŒéçœŸæ­£çš„æ–°é©æ‡‰ç—‡ç™¼ç¾ã€‚</p>

<h3>è‡¨åºŠè©¦é©—</h3>

<table>
<thead>
<tr><th>è©¦é©—ç·¨è™Ÿ</th><th>éšæ®µ</th><th>ç‹€æ…‹</th><th>äººæ•¸</th><th>ä¸»è¦ç™¼ç¾</th></tr>
</thead>
<tbody>
<tr><td><a href="https://clinicaltrials.gov/study/NCT03299166" target="_blank">NCT03299166</a></td><td>PHASE2, PHASE3</td><td>COMPLETED</td><td>426</td><td>A Randomized, Double-blind, Placebo-controlled Trial of Adjunctive Troriluzole i...</td></tr>
<tr><td><a href="https://clinicaltrials.gov/study/NCT04436952" target="_blank">NCT04436952</a></td><td>NA</td><td>WITHDRAWN</td><td>0</td><td>An Open Label Study to Compare and Evaluate the Efficacy of the Deep Transcrania...</td></tr>
<tr><td><a href="https://clinicaltrials.gov/study/NCT01404871" target="_blank">NCT01404871</a></td><td>NA</td><td>COMPLETED</td><td>26</td><td>Predicting Medication Response in Obsessive Compulsive Disorder</td></tr>
<tr><td><a href="https://clinicaltrials.gov/study/NCT02374567" target="_blank">NCT02374567</a></td><td>PHASE3</td><td>TERMINATED</td><td>407</td><td>Pharmacovigilance in Gerontopsychiatric Patients</td></tr>
<tr><td><a href="https://clinicaltrials.gov/study/NCT06942494" target="_blank">NCT06942494</a></td><td>NA</td><td>RECRUITING</td><td>88</td><td>Effect of a Family-Based Cognitive Behavioral Therapy Self-Help Intervention for...</td></tr>
<tr><td><a href="https://clinicaltrials.gov/study/NCT04708834" target="_blank">NCT04708834</a></td><td>PHASE3</td><td>ENROLLING_BY_INVITATION</td><td>1200</td><td>A Multicenter, Long-Term Open-Label Safety Study of Adjunctive Troriluzole in Su...</td></tr>
<tr><td><a href="https://clinicaltrials.gov/study/NCT00004310" target="_blank">NCT00004310</a></td><td>PHASE2</td><td>UNKNOWN</td><td>76</td><td>Phase II Randomized Study of Intravenous Versus Oral Clomipramine in Patients Wi...</td></tr>
<tr><td><a href="https://clinicaltrials.gov/study/NCT05737511" target="_blank">NCT05737511</a></td><td>PHASE4</td><td>NOT_YET_RECRUITING</td><td>80</td><td>Efficacy of Hydroxyzine Versus Treatment as Usual for Panic Disorder: An Eight-W...</td></tr>
<tr><td><a href="https://clinicaltrials.gov/study/NCT02431845" target="_blank">NCT02431845</a></td><td>NA</td><td>RECRUITING</td><td>200</td><td>Pharmaco(Epi)Genetic, Proteomic, and Microbiomic Study of Obsessive-Compulsive</td></tr>
<tr><td><a href="https://clinicaltrials.gov/study/NCT00466609" target="_blank">NCT00466609</a></td><td>PHASE4</td><td>COMPLETED</td><td>54</td><td>Pharmacological Augmentation Strategies for Obsessive Compulsive Disorder Patien...</td></tr>
<tr><td><a href="https://clinicaltrials.gov/study/NCT01148316" target="_blank">NCT01148316</a></td><td>NA</td><td>COMPLETED</td><td>144</td><td>Adaptive Treatment Strategies for Children and Adolescents With Psychiatric Diso...</td></tr>
<tr><td><a href="https://clinicaltrials.gov/study/NCT02450695" target="_blank">NCT02450695</a></td><td>NA</td><td>WITHDRAWN</td><td>0</td><td>A Randomized Crossed-over Trial Examining Efficacy of Repetitive Transcranial Ma...</td></tr>
<tr><td><a href="https://clinicaltrials.gov/study/NCT06659094" target="_blank">NCT06659094</a></td><td>NA</td><td>COMPLETED</td><td>95</td><td>Step Down From Maximal Support: Efficacy of Stepped-care Internet-based Cognitiv...</td></tr>
<tr><td><a href="https://clinicaltrials.gov/study/NCT00564564" target="_blank">NCT00564564</a></td><td>PHASE4</td><td>COMPLETED</td><td>21</td><td>Quetiapine Augmentation Versus Clomipramine Augmentation of Selective Serotonin ...</td></tr>
<tr><td><a href="https://clinicaltrials.gov/study/NCT04989413" target="_blank">NCT04989413</a></td><td>PHASE2, PHASE3</td><td>TERMINATED</td><td>110</td><td>Randomized, Double Blind Clinical Trial to Study the Effect of Cannabidiol (CBD)...</td></tr>
<tr><td><a href="https://clinicaltrials.gov/study/NCT00074815" target="_blank">NCT00074815</a></td><td>PHASE3</td><td>COMPLETED</td><td>124</td><td>Treatment of Pediatric OCD for SRI Partial Responders</td></tr>
<tr><td><a href="https://clinicaltrials.gov/study/NCT00254735" target="_blank">NCT00254735</a></td><td>PHASE3</td><td>COMPLETED</td><td>44</td><td>Quetiapine Augmentation in Severe Obsessive Compulsive Disorder (OCD) - Pilot St...</td></tr>
<tr><td><a href="https://clinicaltrials.gov/study/NCT01944657" target="_blank">NCT01944657</a></td><td>NA</td><td>WITHDRAWN</td><td>0</td><td>Supplemental TMS vs. Standard Medication Monotherapy for Treating Major Depressi...</td></tr>
</tbody>
</table>

<h3>ç›¸é—œæ–‡ç»</h3>

<table>
<thead>
<tr><th>PMID</th><th>å¹´ä»½</th><th>é¡å‹</th><th>æœŸåˆŠ</th><th>ä¸»è¦ç™¼ç¾</th></tr>
</thead>
<tbody>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/38014714/" target="_blank">38014714</a></td><td>2023</td><td>Article</td><td>The Cochrane database of syste</td><td>Pharmacological treatments in panic disorder in adults: a network meta-analysis.</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/3887336/" target="_blank">3887336</a></td><td>1985</td><td>Article</td><td>The Psychiatric clinics of Nor</td><td>Obsessive-compulsive disorder.</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/34582562/" target="_blank">34582562</a></td><td>2021</td><td>Article</td><td>The Cochrane database of syste</td><td>Pharmacotherapy for trichotillomania.</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/11450830/" target="_blank">11450830</a></td><td>2001</td><td>Article</td><td>Journal of the American Animal</td><td>Clomipramine--beyond separation anxiety.</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/24214100/" target="_blank">24214100</a></td><td>2013</td><td>Article</td><td>The Cochrane database of syste</td><td>Pharmacotherapy for trichotillomania.</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/19398818/" target="_blank">19398818</a></td><td>2008</td><td>Article</td><td>The Israel journal of psychiat</td><td>Obsessive-compulsive disorder.</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/22204483/" target="_blank">22204483</a></td><td>2012</td><td>Article</td><td>Current topics in medicinal ch</td><td>Treatment strategies of obsessive-compulsive disorder and panic disorder/agoraph...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/1933762/" target="_blank">1933762</a></td><td>1991</td><td>Article</td><td>Canadian journal of psychiatry</td><td>Intravenous clomipramine and obsessive-compulsive disorder.</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/1474179/" target="_blank">1474179</a></td><td>1992</td><td>Article</td><td>Journal of clinical psychophar</td><td>Clomipramine, clonazepam, and clonidine treatment of obsessive-compulsive disord...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/3887445/" target="_blank">3887445</a></td><td>1985</td><td>Article</td><td>Psychiatry research</td><td>Clomipramine and imipramine in obsessive-compulsive disorder.</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/25681005/" target="_blank">25681005</a></td><td>2015</td><td>Article</td><td>Psychiatry research</td><td>Obsessive-compulsive disorder (OCD): Practical strategies for pharmacological an...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/28470111/" target="_blank">28470111</a></td><td>2017</td><td>Article</td><td>Pharmacogenomics</td><td>Serum clomipramine and desmethylclomipramine levels in a CYP2C19 and CYP2D6 inte...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/36740347/" target="_blank">36740347</a></td><td>2023</td><td>Article</td><td>The Psychiatric clinics of Nor</td><td>The Pharmacological Treatment of Obsessive-Compulsive Disorder.</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/9631696/" target="_blank">9631696</a></td><td>1998</td><td>Article</td><td>Australian veterinary journal</td><td>Use of clomipramine in the treatment of anxiety-related and obsessive-compulsive...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/12063477/" target="_blank">12063477</a></td><td>2002</td><td>Article</td><td>Journal of the American Academ</td><td>Trichotillomania.</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/8263222/" target="_blank">8263222</a></td><td>1993</td><td>Article</td><td>Journal of behavior therapy an</td><td>Clomipramine, fluoxetine, and behavior therapy in the treatment of obsessive-com...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/11349411/" target="_blank">11349411</a></td><td>2001</td><td>Article</td><td>Australian veterinary journal</td><td>Use of clomipramine in treatment of obsessive-compulsive disorder, separation an...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/2178909/" target="_blank">2178909</a></td><td>1990</td><td>Article</td><td>Drugs</td><td>Clomipramine. An overview of its pharmacological properties and a review of its ...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/10665629/" target="_blank">10665629</a></td><td>1999</td><td>Article</td><td>The Journal of clinical psychi</td><td>Paroxetine, clomipramine, and cognitive therapy in the treatment of panic disord...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/27663940/" target="_blank">27663940</a></td><td>2016</td><td>Article</td><td>Journal of the American Academ</td><td>Systematic Review and Meta-Analysis: Early Treatment Responses of Selective Sero...</td></tr>
</tbody>
</table>

</div>
</details>

<details class="indication-section">
<summary>
<span class="indication-name">2. benign paroxysmal torticollis of infancy</span>
<span class="evidence-badge evidence-L5">L5</span>
<span class="prediction-score">99.90%</span>
</summary>
<div class="indication-content">

<div class="no-evidence-notice">
ç›®å‰å°šç„¡é‡å°æ­¤é©æ‡‰ç—‡çš„å°ˆé–€è‡¨åºŠç ”ç©¶ã€‚æ­¤ç‚º TxGNN æ¨¡å‹é æ¸¬çµæœï¼Œéœ€é€²ä¸€æ­¥é©—è­‰ã€‚
</div>

</div>
</details>

<details class="indication-section">
<summary>
<span class="indication-name">3. schizotypal personality disorder</span>
<span class="evidence-badge evidence-L4">L4</span>
<span class="prediction-score">99.90%</span>
</summary>
<div class="indication-content">

<h3>ç›¸é—œæ–‡ç»ï¼ˆ5 ç¯‡ï¼‰</h3>

<table>
<thead>
<tr><th>PMID</th><th>å¹´ä»½</th><th>é¡å‹</th><th>æœŸåˆŠ</th><th>ä¸»è¦ç™¼ç¾</th></tr>
</thead>
<tbody>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/11893994/" target="_blank">11893994</a></td><td>2002</td><td>Article</td><td>Comprehensive psychiatry</td><td>Obsessive-compulsive disorder with poor insight.</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/2265532/" target="_blank">2265532</a></td><td>1990</td><td>Article</td><td>Comprehensive psychiatry</td><td>Correlates of DSM-III personality disorder in obsessive-compulsive disorder.</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/1444723/" target="_blank">1444723</a></td><td>1992</td><td>Article</td><td>Archives of general psychiatry</td><td>Effect of axis II diagnoses on treatment outcome with clomipramine in 55 patient...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/7635854/" target="_blank">7635854</a></td><td>1995</td><td>Article</td><td>The Journal of clinical psychi</td><td>Predictors of drug treatment response in obsessive-compulsive disorder.</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/10897982/" target="_blank">10897982</a></td><td>1999</td><td>Article</td><td>MMW Fortschritte der Medizin</td><td>[Drug treatment of obsessive-compulsive disorder. With proper drugs and some pat...</td></tr>
</tbody>
</table>

</div>
</details>

<details class="indication-section">
<summary>
<span class="indication-name">4. histrionic personality disorder (disease)</span>
<span class="evidence-badge evidence-L5">L5</span>
<span class="prediction-score">99.90%</span>
</summary>
<div class="indication-content">

<div class="no-evidence-notice">
ç›®å‰å°šç„¡é‡å°æ­¤é©æ‡‰ç—‡çš„å°ˆé–€è‡¨åºŠç ”ç©¶ã€‚æ­¤ç‚º TxGNN æ¨¡å‹é æ¸¬çµæœï¼Œéœ€é€²ä¸€æ­¥é©—è­‰ã€‚
</div>

</div>
</details>

<details class="indication-section">
<summary>
<span class="indication-name">5. paranoid personality disorder</span>
<span class="evidence-badge evidence-L4">L4</span>
<span class="prediction-score">99.90%</span>
</summary>
<div class="indication-content">

<h3>ç›¸é—œæ–‡ç»ï¼ˆ2 ç¯‡ï¼‰</h3>

<table>
<thead>
<tr><th>PMID</th><th>å¹´ä»½</th><th>é¡å‹</th><th>æœŸåˆŠ</th><th>ä¸»è¦ç™¼ç¾</th></tr>
</thead>
<tbody>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/2265532/" target="_blank">2265532</a></td><td>1990</td><td>Article</td><td>Comprehensive psychiatry</td><td>Correlates of DSM-III personality disorder in obsessive-compulsive disorder.</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/11407273/" target="_blank">11407273</a></td><td>2001</td><td>Article</td><td>L&#x27;Encephale</td><td>[Psychiatric manifestations of a new variant of Creutzfeldt-Jakob disease. Aprop...</td></tr>
</tbody>
</table>

</div>
</details>

<details class="indication-section">
<summary>
<span class="indication-name">6. schizoid personality disorder</span>
<span class="evidence-badge evidence-L4">L4</span>
<span class="prediction-score">99.90%</span>
</summary>
<div class="indication-content">

<h3>ç›¸é—œæ–‡ç»ï¼ˆ1 ç¯‡ï¼‰</h3>

<table>
<thead>
<tr><th>PMID</th><th>å¹´ä»½</th><th>é¡å‹</th><th>æœŸåˆŠ</th><th>ä¸»è¦ç™¼ç¾</th></tr>
</thead>
<tbody>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/9316681/" target="_blank">9316681</a></td><td>1994</td><td>Article</td><td>Clinical neuropharmacology</td><td>Clomipramine-induced tourettism in obsessive-compulsive disorder: clinical and t...</td></tr>
</tbody>
</table>

</div>
</details>

<details class="indication-section">
<summary>
<span class="indication-name">7. agoraphobia</span>
<span class="evidence-badge evidence-L4">L4</span>
<span class="prediction-score">99.87%</span>
</summary>
<div class="indication-content">

<h3>ç›¸é—œæ–‡ç»ï¼ˆ20 ç¯‡ï¼‰</h3>

<table>
<thead>
<tr><th>PMID</th><th>å¹´ä»½</th><th>é¡å‹</th><th>æœŸåˆŠ</th><th>ä¸»è¦ç™¼ç¾</th></tr>
</thead>
<tbody>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/38014714/" target="_blank">38014714</a></td><td>2023</td><td>Article</td><td>The Cochrane database of syste</td><td>Pharmacological treatments in panic disorder in adults: a network meta-analysis.</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/6373161/" target="_blank">6373161</a></td><td>1984</td><td>Article</td><td>Current medical research and o</td><td>Clomipramine and diazepam in the treatment of agoraphobia and social phobia in g...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/22204483/" target="_blank">22204483</a></td><td>2012</td><td>Article</td><td>Current topics in medicinal ch</td><td>Treatment strategies of obsessive-compulsive disorder and panic disorder/agoraph...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/22290995/" target="_blank">22290995</a></td><td>1993</td><td>Article</td><td>Journal of psychopharmacology </td><td>Clomipramine, a better reference drug for panic/agoraphobia. II. Psychomotor and...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/10221358/" target="_blank">10221358</a></td><td>1999</td><td>Article</td><td>Journal of psychopharmacology </td><td>Serum levels of clomipramine and desmethylclomipramine and clinical improvement ...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/2651491/" target="_blank">2651491</a></td><td>1989</td><td>Article</td><td>Journal of clinical psychophar</td><td>Panic attacks and agoraphobia: low dose clomipramine treatment.</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/10665629/" target="_blank">10665629</a></td><td>1999</td><td>Article</td><td>The Journal of clinical psychi</td><td>Paroxetine, clomipramine, and cognitive therapy in the treatment of panic disord...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/2178909/" target="_blank">2178909</a></td><td>1990</td><td>Article</td><td>Drugs</td><td>Clomipramine. An overview of its pharmacological properties and a review of its ...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/6347516/" target="_blank">6347516</a></td><td>1983</td><td>Article</td><td>Comprehensive psychiatry</td><td>Antidepressants in the treatment of agoraphobia and obsessive-compulsive disorde...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/8575719/" target="_blank">8575719</a></td><td>1995</td><td>Article</td><td>Fortschritte der Neurologie-Ps</td><td>[Panic disorder and agoraphobia: what is effective?].</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/40946318/" target="_blank">40946318</a></td><td>2025</td><td>Article</td><td>Psychotherapy and psychosomati</td><td>Integrative Systematic Review on Pharmacological, Psychotherapeutic, and Neurost...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/9585709/" target="_blank">9585709</a></td><td>1998</td><td>Article</td><td>The American journal of psychi</td><td>Comparison of aerobic exercise, clomipramine, and placebo in the treatment of pa...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/11277602/" target="_blank">11277602</a></td><td>2001</td><td>Article</td><td>Journal of psychopharmacology </td><td>A dose-finding and discontinuation study of clomipramine in panic disorder.</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/19698677/" target="_blank">19698677</a></td><td>1998</td><td>Article</td><td>European psychiatry : the jour</td><td>New treatments for panic.</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/7621388/" target="_blank">7621388</a></td><td>1995</td><td>Article</td><td>Canadian journal of psychiatry</td><td>Clomipramine treatment and behaviour therapy with agoraphobic women.</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/11071019/" target="_blank">11071019</a></td><td>2000</td><td>Article</td><td>Pharmacopsychiatry</td><td>The use of the Panic and Agoraphobia Scale (P &amp; A) in a controlled clinical tria...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/10066007/" target="_blank">10066007</a></td><td>1999</td><td>Article</td><td>Acta psychiatrica Scandinavica</td><td>Comparative effects of low and high doses of clomipramine and placebo in panic d...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/3312397/" target="_blank">3312397</a></td><td>1987</td><td>Article</td><td>International clinical psychop</td><td>Effect of a serotonin precursor and uptake inhibitor in anxiety disorders; a dou...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/12729940/" target="_blank">12729940</a></td><td>2003</td><td>Article</td><td>European neuropsychopharmacolo</td><td>5-HT1A responsivity in patients with panic disorder before and after treatment w...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/10361962/" target="_blank">10361962</a></td><td>1999</td><td>Article</td><td>European archives of psychiatr</td><td>The efficacy and safety of moclobemide compared to clomipramine in the treatment...</td></tr>
</tbody>
</table>

</div>
</details>

<details class="indication-section">
<summary>
<span class="indication-name">8. major depressive disorder</span>
<span class="evidence-badge evidence-L1">L1</span>
<span class="prediction-score">99.77%</span>
</summary>
<div class="indication-content">

<h3>è‡¨åºŠè©¦é©—ï¼ˆ10 é …ï¼‰</h3>

<table>
<thead>
<tr><th>è©¦é©—ç·¨è™Ÿ</th><th>éšæ®µ</th><th>ç‹€æ…‹</th><th>äººæ•¸</th><th>ä¸»è¦ç™¼ç¾</th></tr>
</thead>
<tbody>
<tr><td><a href="https://clinicaltrials.gov/study/NCT00944996" target="_blank">NCT00944996</a></td><td>NA</td><td>COMPLETED</td><td>100</td><td>Assessment of PACAP-BDNF Signaling System Involvement in Etiology and Treatment ...</td></tr>
<tr><td><a href="https://clinicaltrials.gov/study/NCT00704860" target="_blank">NCT00704860</a></td><td>PHASE4</td><td>COMPLETED</td><td>27</td><td>Treatment-Resistant Depression, Hippocampus Atrophy and Serotonin Genetic Polymo...</td></tr>
<tr><td><a href="https://clinicaltrials.gov/study/NCT06942494" target="_blank">NCT06942494</a></td><td>NA</td><td>RECRUITING</td><td>88</td><td>Effect of a Family-Based Cognitive Behavioral Therapy Self-Help Intervention for...</td></tr>
<tr><td><a href="https://clinicaltrials.gov/study/NCT01305707" target="_blank">NCT01305707</a></td><td>PHASE4</td><td>TERMINATED</td><td>104</td><td>Continuation Electroconvulsive Therapy Associated With Pharmacotherapy Versus Ph...</td></tr>
<tr><td><a href="https://clinicaltrials.gov/study/NCT05931965" target="_blank">NCT05931965</a></td><td>NA</td><td>COMPLETED</td><td>88</td><td>Comparative Efficacy of Antidepressants With L-methylfolate, B12, and Magnesium ...</td></tr>
<tr><td><a href="https://clinicaltrials.gov/study/NCT05952713" target="_blank">NCT05952713</a></td><td>N/A</td><td>COMPLETED</td><td>73336</td><td>Comparative Responses to 15 Different Antidepressants in Major Depressive Disord...</td></tr>
<tr><td><a href="https://clinicaltrials.gov/study/NCT06659094" target="_blank">NCT06659094</a></td><td>NA</td><td>COMPLETED</td><td>95</td><td>Step Down From Maximal Support: Efficacy of Stepped-care Internet-based Cognitiv...</td></tr>
<tr><td><a href="https://clinicaltrials.gov/study/NCT04989413" target="_blank">NCT04989413</a></td><td>PHASE2, PHASE3</td><td>TERMINATED</td><td>110</td><td>Randomized, Double Blind Clinical Trial to Study the Effect of Cannabidiol (CBD)...</td></tr>
<tr><td><a href="https://clinicaltrials.gov/study/NCT03548675" target="_blank">NCT03548675</a></td><td>PHASE4</td><td>COMPLETED</td><td>125</td><td>Pharmacogenetics to Improve Personalized Antidepressant Dosing in Patients With ...</td></tr>
<tr><td><a href="https://clinicaltrials.gov/study/NCT01944657" target="_blank">NCT01944657</a></td><td>NA</td><td>WITHDRAWN</td><td>0</td><td>Supplemental TMS vs. Standard Medication Monotherapy for Treating Major Depressi...</td></tr>
</tbody>
</table>

<h3>ç›¸é—œæ–‡ç»ï¼ˆ20 ç¯‡ï¼‰</h3>

<table>
<thead>
<tr><th>PMID</th><th>å¹´ä»½</th><th>é¡å‹</th><th>æœŸåˆŠ</th><th>ä¸»è¦ç™¼ç¾</th></tr>
</thead>
<tbody>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/29477251/" target="_blank">29477251</a></td><td>2018</td><td>Article</td><td>Lancet (London, England)</td><td>Comparative efficacy and acceptability of 21 antidepressant drugs for the acute ...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/27289172/" target="_blank">27289172</a></td><td>2016</td><td>Article</td><td>Lancet (London, England)</td><td>Comparative efficacy and tolerability of antidepressants for major depressive di...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/25911132/" target="_blank">25911132</a></td><td>2015</td><td>Article</td><td>Journal of affective disorders</td><td>Dose equivalents of antidepressants: Evidence-based recommendations from randomi...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/28850959/" target="_blank">28850959</a></td><td>2018</td><td>Article</td><td>Pharmacopsychiatry</td><td>Epileptic Seizures Under Antidepressive Drug Treatment: Systematic Review.</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/30611836/" target="_blank">30611836</a></td><td>2019</td><td>Article</td><td>Progress in neuro-psychopharma</td><td>Pharmacological interventions targeting anhedonia in patients with major depress...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/32982805/" target="_blank">32982805</a></td><td>2020</td><td>Article</td><td>Frontiers in psychiatry</td><td>Antidepressants in Children and Adolescents: Meta-Review of Efficacy, Tolerabili...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/39341084/" target="_blank">39341084</a></td><td>2024</td><td>Article</td><td>European neuropsychopharmacolo</td><td>A higher desmethylclomipramine to clomipramine ratio predicts more effectiveness...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/37155164/" target="_blank">37155164</a></td><td>2023</td><td>Article</td><td>JAMA network open</td><td>Effectiveness of Genotype-Specific Tricyclic Antidepressant Dosing in Patients W...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/3572384/" target="_blank">3572384</a></td><td>1987</td><td>Article</td><td>The Journal of nervous and men</td><td>Clomipramine-induced pancytopenia.</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/38379028/" target="_blank">38379028</a></td><td>2024</td><td>Article</td><td>Acta psychiatrica Scandinavica</td><td>Comparative responses to 17 different antidepressants in major depressive disord...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/34598683/" target="_blank">34598683</a></td><td>2021</td><td>Article</td><td>BMC psychiatry</td><td>Tricyclic antidepressants for major depressive disorder: a comprehensive evaluat...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/11986508/" target="_blank">11986508</a></td><td>2002</td><td>Article</td><td>Psychiatric services (Washingt</td><td>Psychodynamic psychotherapy and clomipramine in the treatment of major depressio...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/23810143/" target="_blank">23810143</a></td><td>2013</td><td>Article</td><td>Asian journal of psychiatry</td><td>Psychotic versus non-psychotic major depressive disorder: a comparative naturali...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/31247926/" target="_blank">31247926</a></td><td>2019</td><td>Article</td><td>International journal of envir</td><td>Indices of Change, Expectations, and Popularity of Biological Treatments for Maj...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/12492769/" target="_blank">12492769</a></td><td>2002</td><td>Article</td><td>Acta psychiatrica Scandinavica</td><td>Treatment strategies in achieving remission in major depressive disorder.</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/14978779/" target="_blank">14978779</a></td><td>2004</td><td>Article</td><td>Depression and anxiety</td><td>Intravenous antidepressants: a review.</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/34389045/" target="_blank">34389045</a></td><td>2021</td><td>Article</td><td>Systematic reviews</td><td>Tricyclic antidepressants versus &#x27;active placebo&#x27;, placebo or no intervention fo...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/31312426/" target="_blank">31312426</a></td><td>2019</td><td>Article</td><td>Therapeutic advances in psycho</td><td>What combinations of agomelatine with other antidepressants could be successful ...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/34034811/" target="_blank">34034811</a></td><td>2021</td><td>Article</td><td>Systematic reviews</td><td>Beneficial and harmful effects of antidepressants versus placebo, &#x27;active placeb...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/41290573/" target="_blank">41290573</a></td><td>2025</td><td>Article</td><td>Translational psychiatry</td><td>Comparative gastrointestinal effects of antidepressants for the acute treatment ...</td></tr>
</tbody>
</table>

</div>
</details>

<details class="indication-section">
<summary>
<span class="indication-name">9. endogenous depression</span>
<span class="evidence-badge evidence-L4">L4</span>
<span class="prediction-score">99.71%</span>
</summary>
<div class="indication-content">

<h3>ç›¸é—œæ–‡ç»ï¼ˆ20 ç¯‡ï¼‰</h3>

<table>
<thead>
<tr><th>PMID</th><th>å¹´ä»½</th><th>é¡å‹</th><th>æœŸåˆŠ</th><th>ä¸»è¦ç™¼ç¾</th></tr>
</thead>
<tbody>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/27289172/" target="_blank">27289172</a></td><td>2016</td><td>Article</td><td>Lancet (London, England)</td><td>Comparative efficacy and tolerability of antidepressants for major depressive di...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/2669440/" target="_blank">2669440</a></td><td>1989</td><td>Article</td><td>Acta psychiatrica Scandinavica</td><td>Moclobemide and clomipramine in endogenous depression. A randomized clinical tri...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/2694201/" target="_blank">2694201</a></td><td>1989</td><td>Article</td><td>Psychiatry research</td><td>Clomipramine and EEG sleep in depression.</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/2005057/" target="_blank">2005057</a></td><td>1991</td><td>Article</td><td>Journal of the American Academ</td><td>Trichotillomania and depression.</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/15994726/" target="_blank">15994726</a></td><td>2005</td><td>Article</td><td>The American journal of psychi</td><td>Dysbetalipoproteinemia and clomipramine.</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/10446735/" target="_blank">10446735</a></td><td>1999</td><td>Article</td><td>The Journal of clinical psychi</td><td>Mirtazapine: clinical overview.</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/3887336/" target="_blank">3887336</a></td><td>1985</td><td>Article</td><td>The Psychiatric clinics of Nor</td><td>Obsessive-compulsive disorder.</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/6215443/" target="_blank">6215443</a></td><td>1982</td><td>Article</td><td>Journal of affective disorders</td><td>Fluvoxamine and chlorimipramine in endogenous depression.</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/11986508/" target="_blank">11986508</a></td><td>2002</td><td>Article</td><td>Psychiatric services (Washingt</td><td>Psychodynamic psychotherapy and clomipramine in the treatment of major depressio...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/2644338/" target="_blank">2644338</a></td><td>1989</td><td>Article</td><td>International clinical psychop</td><td>Fluoxetine in endogenous depression and melancholia versus clomipramine.</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/22516018/" target="_blank">22516018</a></td><td>2012</td><td>Article</td><td>Neuroscience</td><td>Sleep homeostasis and depression: studies with the rat clomipramine model of dep...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/28470111/" target="_blank">28470111</a></td><td>2017</td><td>Article</td><td>Pharmacogenomics</td><td>Serum clomipramine and desmethylclomipramine levels in a CYP2C19 and CYP2D6 inte...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/62147/" target="_blank">62147</a></td><td>1976</td><td>Article</td><td>Lancet (London, England)</td><td>Sleep deprivation and clomipramine in endogenous depression.</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/2199435/" target="_blank">2199435</a></td><td>1990</td><td>Article</td><td>The Journal of clinical psychi</td><td>Worldwide use of clomipramine.</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/14532855/" target="_blank">14532855</a></td><td>2003</td><td>Article</td><td>The Journal of urology</td><td>Alterations in voiding frequency and cystometry in the clomipramine induced mode...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/10460069/" target="_blank">10460069</a></td><td>1999</td><td>Article</td><td>Clinical pharmacology and ther</td><td>Clomipramine dose-effect study in patients with depression: clinical end points ...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/16195134/" target="_blank">16195134</a></td><td>2005</td><td>Article</td><td>Nordic journal of psychiatry</td><td>Orthostatic side effects of clomipramine and moclobemide during treatment for de...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/3929308/" target="_blank">3929308</a></td><td>1985</td><td>Article</td><td>Psychopharmacology</td><td>Orthostatic side effects of clomipramine and citalopram during treatment for dep...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/31376442/" target="_blank">31376442</a></td><td>2019</td><td>Article</td><td>Behavioural brain research</td><td>Zinc improves clomipramine effects on depressive and locomotor behavior and reve...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/8382710/" target="_blank">8382710</a></td><td>1993</td><td>Article</td><td>Journal of affective disorders</td><td>Noradrenergic and serotoninergic depression?</td></tr>
</tbody>
</table>

</div>
</details>

<details class="indication-section">
<summary>
<span class="indication-name">10. attention deficit-hyperactivity disorder</span>
<span class="evidence-badge evidence-L4">L4</span>
<span class="prediction-score">99.58%</span>
</summary>
<div class="indication-content">

<h3>ç›¸é—œæ–‡ç»ï¼ˆ20 ç¯‡ï¼‰</h3>

<table>
<thead>
<tr><th>PMID</th><th>å¹´ä»½</th><th>é¡å‹</th><th>æœŸåˆŠ</th><th>ä¸»è¦ç™¼ç¾</th></tr>
</thead>
<tbody>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/25238582/" target="_blank">25238582</a></td><td>2014</td><td>Article</td><td>The Cochrane database of syste</td><td>Tricyclic antidepressants for attention deficit hyperactivity disorder (ADHD) in...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/32982805/" target="_blank">32982805</a></td><td>2020</td><td>Article</td><td>Frontiers in psychiatry</td><td>Antidepressants in Children and Adolescents: Meta-Review of Efficacy, Tolerabili...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/10418807/" target="_blank">10418807</a></td><td>1999</td><td>Article</td><td>The Journal of clinical psychi</td><td>Aggressive behavior in patients with attention-deficit/hyperactivity disorder, c...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/12185806/" target="_blank">12185806</a></td><td>2002</td><td>Article</td><td>Neurologia i neurochirurgia po</td><td>[Tic syndrome].</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/17207050/" target="_blank">17207050</a></td><td>2007</td><td>Article</td><td>Journal of paediatrics and chi</td><td>Drug therapy for attention-deficit/hyperactivity disorder-like symptoms in autis...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/22583957/" target="_blank">22583957</a></td><td>2012</td><td>Article</td><td>Journal of medical case report</td><td>High dose methylphenidate treatment in adult attention deficit hyperactivity dis...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/39372877/" target="_blank">39372877</a></td><td>2024</td><td>Article</td><td>Neuropsychiatric disease and t</td><td>Updated Systematic Review and Meta-Analysis of Randomized Controlled Trials: Ant...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/6875128/" target="_blank">6875128</a></td><td>1983</td><td>Article</td><td>Journal of the American Academ</td><td>Tricyclic antidepressant and methylphenidate treatment of attention deficit diso...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/1429426/" target="_blank">1429426</a></td><td>1992</td><td>Article</td><td>Journal of the American Academ</td><td>Clomipramine side effects.</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/8496110/" target="_blank">8496110</a></td><td>1993</td><td>Article</td><td>Journal of the American Academ</td><td>Antidepressant treatments in children and adolescents: II. Anxiety, physical, an...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/1537774/" target="_blank">1537774</a></td><td>1992</td><td>Article</td><td>Journal of the American Academ</td><td>Clomipramine for comorbid conditions.</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/1549543/" target="_blank">1549543</a></td><td>1992</td><td>Article</td><td>The Psychiatric clinics of Nor</td><td>Pharmacotherapy of Tourette&#x27;s syndrome and associated disorders.</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/8861545/" target="_blank">8861545</a></td><td>1996</td><td>Article</td><td>Drugs</td><td>Pharmacological treatment of psychiatric disorders in children and adolescents: ...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/9547477/" target="_blank">9547477</a></td><td>1998</td><td>Article</td><td>The Journal of neuropsychiatry</td><td>When fluvoxamine treats only depression and clomipramine treats only obsessive-c...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/7717094/" target="_blank">7717094</a></td><td>1995</td><td>Article</td><td>Acta psychiatrica Scandinavica</td><td>Reversible and selective inhibitors of monoamine oxidase A in mental and other d...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/9242899/" target="_blank">9242899</a></td><td>1997</td><td>Article</td><td>Annals of clinical psychiatry </td><td>Three years on clomipramine: before and after brain SPECT study.</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/9288426/" target="_blank">9288426</a></td><td>1997</td><td>Article</td><td>Canadian journal of psychiatry</td><td>Bipolar disorder in children and adolescents: current challenges.</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/26529542/" target="_blank">26529542</a></td><td>2017</td><td>Article</td><td>The world journal of biologica</td><td>Interaction between methylphenidate, methadone and different antidepressant drug...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/11725521/" target="_blank">11725521</a></td><td>2001</td><td>Article</td><td>No to hattatsu = Brain and dev</td><td>[Narcolepsy in a prepubertal boy].</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/19393386/" target="_blank">19393386</a></td><td>2009</td><td>Article</td><td>L&#x27;Encephale</td><td>[Treatment of a serious autistic disorder in a child with Naltrexone in an oral ...</td></tr>
</tbody>
</table>

</div>
</details>


## å°ç£ä¸Šå¸‚è³‡è¨Š

| è¨±å¯è­‰å­—è™Ÿ | å•†å“å | é©æ‡‰ç—‡ | åŠ‘å‹ | ç‹€æ…‹ |
|------------|--------|--------|------|------|
| å¤šé …è¨±å¯è­‰ | å€æ¬£è†œè¡£éŒ ç­‰ | æ†‚é¬±ç—…ã€å¼·è¿«ç—‡ã€ææ‡¼ç—‡ã€é©šæ‡¼ç™¼ä½œ | éŒ åŠ‘/è† å›Š | æœ‰æ•ˆ |

**å‚™è¨»**ï¼šå°ç£æ ¸å‡†é©æ‡‰ç—‡å·²åŒ…å«ã€Œææ‡¼ç—‡ã€åŠã€Œé©šæ‡¼ç™¼ä½œã€ï¼Œå¯¦è³ªä¸Šæ¶µè“‹äº†ç„¦æ…®ç—‡çš„ä¸»è¦é¡å‹ã€‚

---

## å®‰å…¨æ€§è€ƒé‡

### é‡è¦è­¦èª

1. **å¿ƒè‡Ÿæ¯’æ€§**ï¼šå¯èƒ½å»¶é•· QT é–“æœŸï¼Œå¿ƒè‡Ÿç—…æ‚£è€…éœ€è¬¹æ…ä½¿ç”¨
2. **æŠ—è†½é¹¼å‰¯ä½œç”¨**ï¼šå£ä¹¾ã€ä¾¿ç§˜ã€å°¿æ»¯ç•™ã€è¦–åŠ›æ¨¡ç³Š
3. **é®éœä½œç”¨**ï¼šå¯èƒ½å½±éŸ¿é§•é§›åŠæ“ä½œæ©Ÿæ¢°èƒ½åŠ›
4. **éé‡ä¸­æ¯’é¢¨éšª**ï¼šä¸‰ç’°æŠ—æ†‚é¬±åŠ‘éé‡å¯èƒ½è‡´å‘½
5. **å¹´è¼•äººè‡ªæ®ºé¢¨éšª**ï¼š18-24 æ­²æ‚£è€…åˆæœŸæ²»ç™‚éœ€å¯†åˆ‡ç›£æ¸¬

### è—¥ç‰©äº¤äº’ä½œç”¨æ³¨æ„äº‹é …

- **MAO æŠ‘åˆ¶åŠ‘**ï¼šç¦æ­¢ä½µç”¨ï¼Œå¯èƒ½å°è‡´è¡€æ¸…ç´ ç—‡å€™ç¾¤
- **CYP2D6 æŠ‘åˆ¶åŠ‘**ï¼šå¯èƒ½å¢åŠ  clomipramine è¡€ä¸­æ¿ƒåº¦
- **ä¸­æ¨ç¥ç¶“æŠ‘åˆ¶åŠ‘**ï¼šåŠ å¼·é®éœä½œç”¨
- **æŠ—è†½é¹¼è—¥ç‰©**ï¼šåŠ é‡æŠ—è†½é¹¼å‰¯ä½œç”¨

### CYP450 ä»£è¬è€ƒé‡

Clomipramine ç¶“ç”± CYP2C19 åŠ CYP2D6 ä»£è¬ã€‚æ–‡ç»å ±å‘Š (PMID: 28470111) é¡¯ç¤ºï¼ŒCYP2C19 åŠ CYP2D6 ä¸­é–“ä»£è¬è€…å¯èƒ½å‡ºç¾é¡¯è‘—å‡é«˜çš„è—¥ç‰©è¡€ä¸­æ¿ƒåº¦ï¼Œå»ºè­°è€ƒæ…®è—¥ç‰©åŸºå› æª¢æ¸¬ã€‚

---




### è—¥ç‰©-é£Ÿç‰©äº¤äº’ä½œç”¨ (DFI)

<div class="dfi-source">è³‡æ–™ä¾†æºï¼š<a href="https://ddinter2.scbdd.com/" target="_blank">DDInter 2.0</a>ï¼ˆåŸæ–‡å…§å®¹è«‹åƒé–±è©²ç¶²ç«™ï¼‰</div>

**é…’ç²¾** ğŸŸ¡ Moderate
- å½±éŸ¿ï¼šç”¢ç”Ÿå”åŒä½œç”¨ã€‚
- å»ºè­°ï¼šéœ€ç›£æ¸¬ç™‚æ•ˆæˆ–ä¸è‰¯åæ‡‰ã€‚

**è‘¡è„æŸšæ±** ğŸŸ¡ Moderate
- å½±éŸ¿ï¼šå½±éŸ¿è—¥ç‰©ä»£è¬ã€‚å¯èƒ½å¢åŠ è—¥ç‰©è¡€ä¸­æ¿ƒåº¦ã€‚
- å»ºè­°ï¼šéœ€ç›£æ¸¬ç™‚æ•ˆæˆ–ä¸è‰¯åæ‡‰ã€‚é¿å…é£Ÿç”¨è‘¡è„æŸšæˆ–è‘¡è„æŸšæ±ã€‚

**è”“è¶Šè“æ±** ğŸŸ¡ Moderate
- å½±éŸ¿ï¼šå½±éŸ¿è—¥ç‰©ä»£è¬ã€‚å¯èƒ½å¢åŠ è—¥ç‰©è¡€ä¸­æ¿ƒåº¦ã€‚
- å»ºè­°ï¼šéœ€ç›£æ¸¬ç™‚æ•ˆæˆ–ä¸è‰¯åæ‡‰ã€‚

### è—¥ç‰©-è‰è—¥äº¤äº’ä½œç”¨ (DHI)

**è–ç´„ç¿°è‰ï¼ˆè²«è‘‰é€£ç¿¹ï¼‰** ğŸ”´ Major
- å½±éŸ¿ï¼šä½µç”¨å¯èƒ½å°è‡´è¡€æ¸…ç´ ç—‡å€™ç¾¤
- å»ºè­°ï¼šç¦æ­¢ä½µç”¨

**å¡ç“¦** ğŸ”´ Major
- å½±éŸ¿ï¼šå¡ç“¦å¢å¼·ä¸­æ¨ç¥ç¶“æŠ‘åˆ¶ä½œç”¨
- å»ºè­°ï¼šé¿å…ä½µç”¨

**çºˆè‰** ğŸŸ¡ Moderate
- å½±éŸ¿ï¼šçºˆè‰å¯èƒ½å¢å¼·é®éœä½œç”¨
- å»ºè­°ï¼šè¬¹æ…ä½¿ç”¨


### è—¥ç‰©-ç–¾ç—…æ³¨æ„äº‹é … (DDSI)

<div class="ddsi-source">è³‡æ–™ä¾†æºï¼š<a href="https://ddinter2.scbdd.com/" target="_blank">DDInter 2.0</a>ï¼ˆåŸæ–‡å…§å®¹è«‹åƒé–±è©²ç¶²ç«™ï¼‰</div>

**Adrenal Gland Neoplasms** ğŸŸ¡ Moderate
- æ‡‰è¬¹æ…ä½¿ç”¨æœ¬è—¥ç‰©ã€‚

**Mania** ğŸŸ¡ Moderate
- æ³¨æ„äº‹é …ï¼šPremarketing studies reported activation of mania/hypomania in patients with affective disorders treated with clomipramine...

**Bone Marrow Failure Disorders** ğŸŸ¡ Moderate
- éœ€å¯†åˆ‡ç›£æ¸¬ã€‚é¢¨éšªåŒ…æ‹¬ï¼šéª¨é«“æŠ‘åˆ¶ã€è¡€æ “ã€è²§è¡€ã€‚

**ç³–å°¿ç—…** ğŸŸ¡ Moderate
- éœ€å®šæœŸç›£æ¸¬ã€‚

**è‚è‡Ÿç–¾ç—…** ğŸŸ¡ Moderate
- å¯èƒ½éœ€è¦èª¿æ•´åŠ‘é‡ã€‚

**Schizophrenia** ğŸŸ¡ Moderate
- æ³¨æ„äº‹é …ï¼šTricyclic antidepressants (TCAs) may aggravate symptoms of psychosis in schizophrenic patients, particularly those with paranoid symptomatology...

**Tardive Dyskinesia** ğŸŸ¡ Moderate
- éœ€å®šæœŸç›£æ¸¬ã€‚ç‰¹åˆ¥æ³¨æ„æ—ç¾¤ï¼šè€å¹´äººã€‚

**Alcoholic Intoxication** ğŸŸ¡ Moderate
- æ³¨æ„äº‹é …ï¼šTricyclic antidepressants can enhance the response to alcohol...

**èºé¬±ç—‡** ğŸŸ¡ Moderate
- æ³¨æ„äº‹é …ï¼šA major depressive episode can be the initial presentation of bipolar disorder...

**é’å…‰çœ¼** ğŸŸ¡ Moderate
- æœ¬è—¥ç‰©åœ¨æ­¤æƒ…æ³ä¸‹ç¦ç”¨ã€‚

**ç³–å°¿ç—…** ğŸŸ¡ Moderate
- æ‡‰è¬¹æ…ä½¿ç”¨æœ¬è—¥ç‰©ã€‚éœ€å®šæœŸç›£æ¸¬ã€‚é¢¨éšªåŒ…æ‹¬ï¼šä½è¡€ç³–ã€é«˜è¡€ç³–ã€‚

**è‚è‡Ÿç–¾ç—…** ğŸŸ¡ Moderate
- æ‡‰è¬¹æ…ä½¿ç”¨æœ¬è—¥ç‰©ã€‚éœ€å®šæœŸç›£æ¸¬ã€‚å¯èƒ½æœ‰åš´é‡ä¸è‰¯åæ‡‰ã€‚ç‰¹åˆ¥æ³¨æ„æ—ç¾¤ï¼šè€å¹´äººã€‚

**Neutropenia** ğŸŸ¡ Moderate
- å¿…è¦æ™‚æ‡‰åœæ­¢æ²»ç™‚ã€‚

**Schizophrenia** ğŸŸ¡ Moderate
- æ³¨æ„äº‹é …ï¼šSome tricyclic antidepressants have shown to cause activation or exacerbation of psychosis in schizophrenic patients...

**Thyroid Diseases** ğŸŸ¡ Moderate
- æ‡‰è¬¹æ…ä½¿ç”¨æœ¬è—¥ç‰©ã€‚é¢¨éšªåŒ…æ‹¬ï¼šå¿ƒå¾‹ä¸æ•´ã€‚

**å°¿æ»¯ç•™** ğŸŸ¡ Moderate
- æœ¬è—¥ç‰©åœ¨æ­¤æƒ…æ³ä¸‹ç¦ç”¨ã€‚

**Anticholinergic Syndrome** ğŸŸ¢ Minor
- éœ€å®šæœŸç›£æ¸¬ã€‚é¢¨éšªåŒ…æ‹¬ï¼šè¡€å£“æ§åˆ¶ä¸è‰¯ã€‚ç‰¹åˆ¥æ³¨æ„æ—ç¾¤ï¼šè€å¹´äººã€‚

**å¿ƒè¡€ç®¡ç–¾ç—…** ğŸŸ¢ Minor
- æ‡‰é¿å…ä½¿ç”¨æœ¬è—¥ç‰©ã€‚éœ€å®šæœŸç›£æ¸¬ã€‚é¢¨éšªåŒ…æ‹¬ï¼šä½è¡€å£“ã€å¿ƒå¾‹ä¸æ•´ã€è¡€æ “ã€‚å¯èƒ½æœ‰è‡´å‘½é¢¨éšªã€‚

**Pheochromocytoma** ğŸŸ¢ Minor
- æ³¨æ„äº‹é …ï¼šTricyclic and tetracyclic antidepressants (TCAs) may potentiate the effects of circulating catecholamines...

**Acute Myocardial Infarction Recovery** ğŸŸ¢ Minor
- æœ¬è—¥ç‰©åœ¨æ­¤æƒ…æ³ä¸‹ç¦ç”¨ã€‚

**Depressive Disorder** ğŸŸ¢ Minor
- éœ€å¯†åˆ‡ç›£æ¸¬ã€‚ç‰¹åˆ¥æ³¨æ„æ—ç¾¤ï¼šå…’ç«¥ã€‚

**ç™²ç™‡** ğŸŸ¢ Minor
- æ‡‰è¬¹æ…ä½¿ç”¨æœ¬è—¥ç‰©ã€‚é¢¨éšªåŒ…æ‹¬ï¼šç™²ç™‡ç™¼ä½œã€‚

## çµè«–èˆ‡ä¸‹ä¸€æ­¥

### é æ¸¬è©•ä¼°

| è©•ä¼°é …ç›® | çµæœ |
|----------|------|
| æ©Ÿè½‰åˆç†æ€§ | é«˜ - è¡€æ¸…ç´ /æ­£è…ä¸Šè…ºç´ å†å¸æ”¶æŠ‘åˆ¶å°ç„¦æ…®ç—‡æœ‰æ˜ç¢ºç™‚æ•ˆ |
| è‡¨åºŠè­‰æ“š | å……è¶³ - å¤šé … RCT åŠ meta-analysis æ”¯æŒ |
| æ–‡ç»æ”¯æŒ | å¼· - åœ‹éš›æŒ‡å¼•æ¨è–¦ |
| æ•´é«”è­‰æ“šç­‰ç´š | **L1-L2 (å¤šå€‹ RCT/ç³»çµ±æ€§å›é¡§)** |

### è‡¨åºŠå»ºè­°

1. **å·²å¯è‡¨åºŠä½¿ç”¨**ï¼šClomipramine å°ç„¦æ…®ç›¸é—œç–¾æ‚£ï¼ˆç‰¹åˆ¥æ˜¯ OCDã€ææ…Œç—‡ï¼‰çš„ç™‚æ•ˆå·²ç²ç¢ºèª
2. **é©æ‡‰ç—‡è€ƒé‡**ï¼šå°ç£æ ¸å‡†é©æ‡‰ç—‡å·²æ¶µè“‹å¤šç¨®ç„¦æ…®ç–¾æ‚£ï¼Œç¬¦åˆä»¿å–®é©æ‡‰ç—‡ä½¿ç”¨
3. **è™•æ–¹æ³¨æ„äº‹é …**ï¼š
   - èµ·å§‹åŠ‘é‡å®œä½ï¼Œç·©æ…¢èª¿å‡
   - ç›£æ¸¬å¿ƒé›»åœ–ï¼Œç‰¹åˆ¥æ˜¯æœ‰å¿ƒè‡Ÿç—…å²è€…
   - æ³¨æ„å¹´è¼•æ‚£è€…çš„è‡ªæ®ºé¢¨éšª
   - é¿å…çªç„¶åœè—¥

### çµèª

æ­¤é æ¸¬é©—è­‰äº† TxGNN çŸ¥è­˜åœ–è­œæ–¹æ³•èƒ½æº–ç¢ºè­˜åˆ¥è—¥ç‰©çš„å·²çŸ¥æ²»ç™‚æ½›åŠ›ã€‚Clomipramine å°ç„¦æ…®ç—‡çš„ç™‚æ•ˆå·²æœ‰å …å¯¦çš„è­‰æ“šåŸºç¤ï¼Œå±¬æ–¼ã€Œå†ç™¼ç¾ã€è€Œéã€Œæ–°ç™¼ç¾ã€ã€‚

---

*æœ¬ç­†è¨˜åƒ…ä¾›ç ”ç©¶åƒè€ƒï¼Œä¸æ§‹æˆé†«ç™‚å»ºè­°ã€‚ä»»ä½•ç”¨è—¥æ±ºç­–æ‡‰è«®è©¢å°ˆæ¥­é†«ç™‚äººå“¡ã€‚*

*æœ€å¾Œæ›´æ–°ï¼š2026-02-11*

---

## ç›¸é—œè—¥ç‰©å ±å‘Š

- [Amorolfine]({{ "/drugs/amorolfine/" | relative_url }}) - è­‰æ“šç­‰ç´š L5
- [Urea]({{ "/drugs/urea/" | relative_url }}) - è­‰æ“šç­‰ç´š L5
- [Paclitaxel]({{ "/drugs/paclitaxel/" | relative_url }}) - è­‰æ“šç­‰ç´š L5
- [Cobicistat]({{ "/drugs/cobicistat/" | relative_url }}) - è­‰æ“šç­‰ç´š L5
- [Xylometazoline]({{ "/drugs/xylometazoline/" | relative_url }}) - è­‰æ“šç­‰ç´š L5

---

{% include ai-analysis.html %}

{% include social-share.html %}

## å¼•ç”¨æœ¬å ±å‘Š

å¦‚éœ€å¼•ç”¨æœ¬å ±å‘Šï¼Œè«‹ä½¿ç”¨ä»¥ä¸‹æ ¼å¼ï¼š

**APA æ ¼å¼ï¼š**
```
TwTxGNN. (2026). Clomipramineè€è—¥æ–°ç”¨é©—è­‰å ±å‘Š. https://twtxgnn.yao.care/drugs/clomipramine/
```

**BibTeX æ ¼å¼ï¼š**
```bibtex
@misc{twtxgnn_clomipramine,
  title = {Clomipramineè€è—¥æ–°ç”¨é©—è­‰å ±å‘Š},
  author = {TwTxGNN Team},
  year = {2026},
  url = {https://twtxgnn.yao.care/drugs/clomipramine/}
}
```

---

<div class="disclaimer">
<strong>å…è²¬è²æ˜</strong><br>
æœ¬å ±å‘Šåƒ…ä¾›å­¸è¡“ç ”ç©¶åƒè€ƒï¼Œ<strong>ä¸æ§‹æˆé†«ç™‚å»ºè­°</strong>ã€‚è—¥ç‰©ä½¿ç”¨è«‹éµå¾ªé†«å¸«æŒ‡ç¤ºï¼Œåˆ‡å‹¿è‡ªè¡Œèª¿æ•´ç”¨è—¥ã€‚ä»»ä½•è€è—¥æ–°ç”¨æ±ºç­–éœ€ç¶“éå®Œæ•´çš„è‡¨åºŠé©—è­‰èˆ‡æ³•è¦å¯©æŸ¥ã€‚
<br><br>
<small>æœ€å¾Œå¯©æ ¸ï¼š2026-02-20 | å¯©æ ¸è€…ï¼šTwTxGNN Research Team</small>
</div>

{% include giscus.html %}
